Walgreens is now offering RSV vaccines for older adults

1 year ago 80

Respiratory syncytial microorganism viral vaccine nether research.

Hailshadow | Istock | Getty Images

Walgreens is present offering the respiratory syncytial microorganism vaccine for older adults nationwide, the pharmacy concatenation said connected Tuesday.

People ages 60 and older tin docket an assignment this week done Walgreens' app, website, by telephone oregon by visiting their section pharmacy.

related investing news

 How to commercialized   immoderate   of the biggest reports this week, including Apple

CNBC Pro

The RSV vaccines are present disposable astatine Walgreens successful astir states and appointments volition beryllium added connected a rolling ground implicit the adjacent 2 weeks arsenic much pharmacies person the shots, according to the company.

This is the archetypal RSV play successful which older adults person the enactment to get vaccinated against the virus. The Food and Drug Administration approved the archetypal RSV vaccines, made by Pfizer and GSK, past spring. The vaccines are administered arsenic a azygous dose.

RSV starts spreading much wide successful the fall. The microorganism kills 6,000 to 10,000 older adults and hospitalizes 60,000 to 160,000 each year, according to the Centers for Disease Control and Prevention.

The CDC has said eligible adults should speech to their doc astir whether they should person the shot.

CNBC has asked CVS whether it volition besides person RSV vaccines disposable up of the fall.

Pfizer started straight shipping its RSV vaccine to customers past period and has capable banal to conscionable demand, a institution spokesperson said. CNBC has reached retired to GSK for comment.

Pfizer's changeable was 85.7% effectual astatine preventing much terrible little respiratory tract illness during the patient's archetypal RSV play aft vaccination. The shot's efficacy declined slightly to 78.6% astir 18 months aft vaccination.

GSK's changeable was 94% effectual against terrible RSV illness successful the patient's play aft vaccination. The shot's efficacy declined to astir 78.8% aft 2 RSV seasons.

-- CNBC'S Annika Kim Constantino contributed to this story.

Read Entire Article